173 related articles for article (PubMed ID: 27321340)
1. Cystic Fibrosis-Related Diabetes with strict glycaemic control is not associated with frequent intravenous antibiotics use for pulmonary infections.
Belle-van Meerkerk G; de Valk HW; Stam-Slob MC; Teding van Berkhout F; Zanen P; van de Graaf EA
Diabetes Res Clin Pract; 2016 Jun; 116():230-6. PubMed ID: 27321340
[TBL] [Abstract][Full Text] [Related]
2. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control and FEV
Okoniewski W; Hughan KS; Weiner GA; Weiner DJ; Forno E
J Cyst Fibros; 2020 May; 19(3):460-465. PubMed ID: 31980357
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
Yung B; Kemp M; Hooper J; Hodson ME
Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
[TBL] [Abstract][Full Text] [Related]
5. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
[TBL] [Abstract][Full Text] [Related]
8. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
[TBL] [Abstract][Full Text] [Related]
9. Abnormal glucose tolerance in a pediatric cystic fibrosis cohort: Trends in clinical outcomes and associated factors in the preceding years.
Nguyen CQT; Denis MH; Chagnon M; Rabasa-Lhoret R; Mailhot G
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):277-285. PubMed ID: 32981797
[TBL] [Abstract][Full Text] [Related]
10. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
Scully KJ; Sherwood JS; Martin K; Ruazol M; Marchetti P; Larkin M; Zheng H; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Wexler DJ; Putman MS
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1444-e1454. PubMed ID: 34850006
[TBL] [Abstract][Full Text] [Related]
11. The size of the spleen by magnetic resonance imaging in patients with cystic fibrosis; with and without diabetes--a novel observational study.
Jarad NA; Sequeiros IM; Hester K; Callaway M; Williams AJ; Sund Z; Powell T; Wong FS
QJM; 2010 Apr; 103(4):237-42. PubMed ID: 20139101
[TBL] [Abstract][Full Text] [Related]
12. Screening for cystic fibrosis-related diabetes: a systematic review.
Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
[TBL] [Abstract][Full Text] [Related]
13. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
15. Clinical updates in cystic fibrosis-related diabetes.
Brennan AL; Beynon J
Semin Respir Crit Care Med; 2015 Apr; 36(2):236-50. PubMed ID: 25826591
[TBL] [Abstract][Full Text] [Related]
16. Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD).
Suppakitjanusant P; Kasemkosin N; Sivapiromrat AK; Weinstein S; Ongphiphadhanakul B; Hunt WR; Sueblinvong V; Tangpricha V
Sci Rep; 2023 May; 13(1):8617. PubMed ID: 37244957
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis-related diabetes in adults.
Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Chung WY; Gibney J; O'Shea D
Ir Med J; 2006 Mar; 99(3):83-6. PubMed ID: 16700261
[TBL] [Abstract][Full Text] [Related]
18. Long-term benefits in lung function and nutritional status of strict metabolic control of cystic fibrosis-related diabetes.
Martín-Frías M; Máiz L; Carcavilla A; Barrio R
Arch Bronconeumol; 2011 Oct; 47(10):531-4. PubMed ID: 21798655
[TBL] [Abstract][Full Text] [Related]
19. Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study.
Racine F; Shohoudi A; Boudreau V; Nguyen CQT; Denis MH; Desjardins K; Reynaud Q; Rabasa-Lhoret R; Mailhot G
Can J Diabetes; 2021 Dec; 45(8):768-774. PubMed ID: 33926819
[TBL] [Abstract][Full Text] [Related]
20. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]